Search clinical trials for: TP regimen

Total 1565 results

Tianjin Medical University Cancer Institute and...
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients (NSCLC)

Non-small Cell Lung Cancer

China
Chongqing University Cancer Hospital

Unknown

A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity.

Cervical Cancer

China
Emory University
Cooperative for Assistance and Relief Everywhere, Inc. (CARE)

Completed

Preventing Early Child Marriage in Nepal

Child Marriage

Nepal
Tarsus Pharmaceuticals, Inc.

Completed

Study to Evaluate the Food Effect of TP-05 in Healthy Participants

Healthy

United States
San Gerardo Hospital

Completed

Near Infrared Spectroscopy (NIRS) and Superior Mesenteric Artery (SMA) Doppler Patterns as Predictor of Feeding Tolerance in Very Low Birth Weight (VLBW) IntraUterine Growth Restricted (IUGR) and NON IUGR Infants

Infant, Very Low Birth Weight | Infant Malnutrition | Feeding Disorder of Infancy or Early Childhood | Splanchnic Oximetry | Splanchnic Oxygenation

Italy
International Centre for Diarrhoeal Disease Research...
CARE Bangladesh; Gram Bikash Kendra (GBK); CARE USA

Recruiting

Evaluation of Tipping Point

Child Marriage

Bangladesh
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Crohn Disease | Colitis, Ulcerative

United States, Hungary, Poland, Czechia, Japan, Belgium, Spain, Bulgaria, France, Italy, Slovakia, Austria
Sumitomo Pharma America, Inc.

Terminated

Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors

Sarcoma | Ewing Sarcoma | Advanced Solid Tumors | Synovial Sarcoma | Dedifferentiated Liposarcoma

United States
St George's, University of London
Neovii Biotech

Withdrawn

Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy (TEETPIM)

Mitochondrial Diseases | Inborn Errors of Metabolism | Metabolic Disease
Sichuan Provincial People's Hospital

Unknown

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

HER2-negative Breast Cancer

China
Technophage, SA
VectorB2B

Not yet recruiting

Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia (RECOVER)

Pneumonia, Ventilator-Associated

France
Sumitomo Pharma America, Inc.

Terminated

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Anemia in Myelodysplastic Syndromes

United States
Sumitomo Pharma America, Inc.

Recruiting

Phase 1 Study of Oral TP-1454

Advanced Solid Tumor | Anal Cancer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-2)

Blepharitis

United States
National Taiwan University Hospital

Unknown

Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer

Esophageal Cancer

Taiwan
ViiV Healthcare
GlaxoSmithKline

Completed

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Infection, Human Immunodeficiency Virus I
Sumitomo Pharma America, Inc.

Recruiting

A Study of Oral TP-3654 in Patients With Myelofibrosis

Myelofibrosis

United States, Japan, Australia
Sumitomo Pharma America, Inc.

Completed

Study of TP-3654 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Aljazeera Hospital
Cairo University

Completed

Evaluation of TP US in Women With Prolapse

Prolapse

Egypt
Universitat Jaume I

Not yet recruiting

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

Anxiety Disorders | Depressive Disorders
Sumitomo Pharma America, Inc.

Terminated

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLL

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

End Stage Renal Disease
Tarsus Pharmaceuticals, Inc.

Active, not recruiting

A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Healthy Volunteer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)

Meibomian Gland Dysfunction | Blepharitis | Demodex Infestation

United States
Aljazeera Hospital
Kasr El Aini Hospital

Unknown

Evaluation of Labour Progress by PC Angle

Labour

Egypt
Tarsus Pharmaceuticals, Inc.

Completed

A Pharmacokinetic Study of TP-05 in Healthy Subjects

Healthy

United States
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.

Non Small Cell Lung Cancer

China
Dilara Aydin Tozlu

Not yet recruiting

The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study

Sudden Infant Death
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Glioblastoma Multiforme
Peking University Cancer Hospital & Institute

Active, not recruiting

Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Hospital El Cruce

Completed

Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2 (VILIVORTEX)

ARDS | Ventilator-Induced Lung Injury | Mechanical Ventilation Complication

Argentina
National Institute of Diabetes and Digestive and...

Completed

North American Study for the Treatment of Refractory Ascites (NASTRA)

Liver Cirrhosis | Ascites

United States, Canada
Tarsus Pharmaceuticals, Inc.

Completed

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

Blepharitis

United States
Fudan University

Recruiting

Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma (INSIGHT)

Laryngeal Cancer | Laryngeal Neoplasms | Hypopharynx Cancer

China
Qingdao Central Hospital

Recruiting

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Metastatic Esophageal Squamous Cell Carcinoma

China
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated Melanoma

United States
Hospital El Cruce

Completed

The Role of Morphological Phenotype in ARDS (MPARDS)

Respiratory Distress Syndrome, Adult

Argentina
MedMira Laboratories Inc.
Public Health Agency of Canada (PHAC)

Recruiting

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

Syphilis | Syphilis Infection | Early Syphilis, Symptomatic

Canada
Technophage, SA
VectorB2B

Recruiting

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

Diabetic Foot Infection

United States, India
University of Alabama at Birmingham

Completed

Gait Training Combined With Behavioral Strategies for People With Stroke

Stroke | Gait, Hemiplegic | Behavior and Behavior Mechanisms

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

Pneumonia

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Safety and PK Study of IV Eravacycline

Bacterial Infections

United States
Medical University of South Carolina

Terminated

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Hematological Malignancies

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | Neoadjuvant Chemotherapy

China
Pearl Therapeutics, Inc.

Completed

A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

Chronic Obstructive Pulmonary Disease

United States
Albany Medical College

Recruiting

Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications (ProBE-PC)

Prostate Cancer | Infection | PSA

United States
Technophage, SA
VectorB2B

Completed

Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (REVERSE)

Diabetic Foot Ulcer | Staphylococcus Aureus Infection | Pseudomonas Aeruginosa Infection | Acinetobacter Infection

Israel
Cancer Institute and Hospital, Chinese Academy...
The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaborators

Recruiting

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Esophageal Neoplasms

China
GlaxoSmithKline

Completed

An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor

Cancer

United States

Search clinical trials for: TP regimen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations